- ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
INCA 32459-101: A Phase 1, Open-Label, Multicenter Study of INCA32459 in Participants With Select Advanced Malignancies
This study is testing a new medicine, INCA32459, for people with certain advanced cancers like melanoma or lymphoma. It's an early-stage study to see how the medicine works and if it's safe.
Belgium · Spain · Italy - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A safety study of PF-08046045/SGN-35T in adults with advanced cancers
This study is looking at a new medicine for people with certain advanced cancers, including different types of lymphoma. It's the first time this medicine is being given to people, to check if it's safe and how it works in the body.
Germany · Spain · Denmark